European Pharmaceutical Review

OCTOBER 19, 2023

billion deal, in which Eli Lilly agreed to acquire two of POINT Biopharma Global’s late-stage radioligand therapies for oncological indications. One aspect that is extremely promising about radiopharmaceutical therapeutics is that they do not give a patient the side effects that are commonly experienced with chemotherapy.

Food and Drug Administration 87

Food and Drug Administration Side effects Manufacturing Doctors 87

Clarivate

AUGUST 17, 2022

I worked as a hospital doctor for several years and then as a GP for several years, and it became very apparent that there was not enough information for patients to help them to better understand their illnesses, better understand their treatment [and] what to do with their medications. Dr. Grace Lomax : Yes, happily.

Healthcare 52

Healthcare Healthcare Patients Physicians 52

PM360

JUNE 11, 2022

Regardless of the tactics and strategies employed, I would encourage more biopharma professionals to get personally involved in patient engagement programs. Typically, we think of patient partnerships in terms of their external impact—for example, to help educate doctors and payers. Different patients have unique needs. Anthony Yanni.

Patients 59

Patients Pharma Education Media 59